BioNanovations
Charleson is a PhD candidate at Vanderbilt University's biomedical engineering program. The culmination of Charleson’s previous studies in low analyte detection of cancer biomarkers and the fabrication of novel nanoparticles with his current studies regarding the treatment of multi-drug resistant bacteria, lead him to devise the technology behind BioNanovations’ diagnostic strategy.
This person is not in any offices
BioNanovations
BioNanovations develops medical devices infused with novel bionanotechnology-based strategies. These strategies make current medical devices point-of-care, smaller in size, portable, temporally efficient, easy to use, and inexpensive.